These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30882133)

  • 21. Mexiletine rescues a mixed biophysical phenotype of the cardiac sodium channel arising from the SCN5A mutation, N406K, found in LQT3 patients.
    Hu RM; Tester DJ; Li R; Sun T; Peterson BZ; Ackerman MJ; Makielski JC; Tan BH
    Channels (Austin); 2018; 12(1):176-186. PubMed ID: 29983085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Larger late sodium current density as well as greater sensitivities to ATX II and ranolazine in rabbit left atrial than left ventricular myocytes.
    Luo A; Ma J; Song Y; Qian C; Wu Y; Zhang P; Wang L; Fu C; Cao Z; Shryock JC
    Am J Physiol Heart Circ Physiol; 2014 Feb; 306(3):H455-61. PubMed ID: 24322614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Valsartan reduced the vulnerability to atrial fibrillation by preventing action potential prolongation and conduction slowing in castrated male mice.
    Sun YL; Li PH; Shi L; Su WZ; Li DS; Xue GL; Zhao Y; Li CZ; Li Y; Zhou Y; Li SX; Zhang Y; Lu YJ; Pan ZW
    J Cardiovasc Electrophysiol; 2018 Oct; 29(10):1436-1443. PubMed ID: 30016000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitions of late INa and CaMKII act synergistically to prevent ATX-II-induced atrial fibrillation in isolated rat right atria.
    Liang F; Fan P; Jia J; Yang S; Jiang Z; Karpinski S; Kornyeyev D; Pagratis N; Belardinelli L; Yao L
    J Mol Cell Cardiol; 2016 May; 94():122-130. PubMed ID: 27066997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Remodeling of atrial ATP-sensitive K⁺ channels in a model of salt-induced elevated blood pressure.
    Lader JM; Vasquez C; Bao L; Maass K; Qu J; Kefalogianni E; Fishman GI; Coetzee WA; Morley GE
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H964-74. PubMed ID: 21724863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atrial-selective targeting of arrhythmogenic phase-3 early afterdepolarizations in human myocytes.
    Morotti S; McCulloch AD; Bers DM; Edwards AG; Grandi E
    J Mol Cell Cardiol; 2016 Jul; 96():63-71. PubMed ID: 26241847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dysfunctional Nav1.5 channels due to SCN5A mutations.
    Han D; Tan H; Sun C; Li G
    Exp Biol Med (Maywood); 2018 Jun; 243(10):852-863. PubMed ID: 29806494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of moricizine block of sodium current in isolated guinea-pig atrial myocytes. Atrioventricular difference of moricizine block.
    Ahmmed GU; Hisatome I; Kurata Y; Makita N; Tanaka Y; Tanaka H; Okamura T; Sonoyama K; Furuse Y; Kato M; Yamamoto Y; Ogura K; Shimoyama M; Miake J; Sasaki N; Ogino K; Igawa O; Yoshida A; Shigemasa C
    Vascul Pharmacol; 2002 Mar; 38(3):131-41. PubMed ID: 12402511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Telmisartan reduces atrial arrhythmia susceptibility through the regulation of RAS-ERK and PI3K-Akt-eNOS pathways in spontaneously hypertensive rats.
    Wang WW; Zhang FL; Chen JH; Chen XH; Fu FY; Tang MR; Chen LL
    Can J Physiol Pharmacol; 2015 Aug; 93(8):657-65. PubMed ID: 26158699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relaxin suppresses atrial fibrillation in aged rats by reversing fibrosis and upregulating Na+ channels.
    Henry BL; Gabris B; Li Q; Martin B; Giannini M; Parikh A; Patel D; Haney J; Schwartzman DS; Shroff SG; Salama G
    Heart Rhythm; 2016 Apr; 13(4):983-91. PubMed ID: 26711798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human induced pluripotent stem cell-derived atrial cardiomyocytes carrying an SCN5A mutation identify nitric oxide signaling as a mediator of atrial fibrillation.
    Hong L; Zhang M; Ly OT; Chen H; Sridhar A; Lambers E; Chalazan B; Youn SW; Maienschein-Cline M; Feferman L; Ong SG; Wu JC; Rehman J; Darbar D
    Stem Cell Reports; 2021 Jun; 16(6):1542-1554. PubMed ID: 34019817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Caveolin-3 suppresses late sodium current by inhibiting nNOS-dependent S-nitrosylation of SCN5A.
    Cheng J; Valdivia CR; Vaidyanathan R; Balijepalli RC; Ackerman MJ; Makielski JC
    J Mol Cell Cardiol; 2013 Aug; 61():102-10. PubMed ID: 23541953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ion Channel and Structural Remodeling in Obesity-Mediated Atrial Fibrillation.
    McCauley MD; Hong L; Sridhar A; Menon A; Perike S; Zhang M; da Silva IB; Yan J; Bonini MG; Ai X; Rehman J; Darbar D
    Circ Arrhythm Electrophysiol; 2020 Aug; 13(8):e008296. PubMed ID: 32654503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of the cardiac sodium channel Na
    Matasic DS; Yoon JY; McLendon JM; Mehdi H; Schmidt MS; Greiner AM; Quinones P; Morgan GM; Boudreau RL; Irani K; Brenner C; London B
    J Mol Cell Cardiol; 2020 Apr; 141():70-81. PubMed ID: 32209328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in cardiac Nav1.5 expression, function, and acetylation by pan-histone deacetylase inhibitors.
    Xu Q; Patel D; Zhang X; Veenstra RD
    Am J Physiol Heart Circ Physiol; 2016 Nov; 311(5):H1139-H1149. PubMed ID: 27638876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Probucol prevents atrial ion channel remodeling in an alloxan-induced diabetes rabbit model.
    Fu H; Li G; Liu C; Li J; Cheng L; Yang W; Tse G; Zhao J; Liu T
    Oncotarget; 2016 Dec; 7(51):83850-83858. PubMed ID: 27863381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreasing microtubule detyrosination modulates Nav1.5 subcellular distribution and restores sodium current in mdx cardiomyocytes.
    Nasilli G; de Waal TM; Marchal GA; Bertoli G; Veldkamp MW; Rothenberg E; Casini S; Remme CA
    Cardiovasc Res; 2024 May; 120(7):723-734. PubMed ID: 38395031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B-Type Natriuretic Peptide Modulates Pulmonary Vein Arrhythmogenesis: A Novel Potential Contributor to the Genesis of Atrial Tachyarrhythmia in Heart Failure.
    Lin YK; Chen YC; Chen YA; Yeh YH; Chen SA; Chen YJ
    J Cardiovasc Electrophysiol; 2016 Dec; 27(12):1462-1471. PubMed ID: 27571932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of voltage-gated sodium current and inhibition of erg-mediated potassium current caused by telmisartan, an antagonist of angiotensin II type-1 receptor, in HL-1 atrial cardiomyocytes.
    Chang WT; Wu SN
    Clin Exp Pharmacol Physiol; 2018 Aug; 45(8):797-807. PubMed ID: 29617054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blockade of brain angiotensin II type 1 receptor inhibits the development of atrial fibrillation in hypertensive rats.
    Nagayama T; Hirooka Y; Kishi T; Mukai Y; Inoue S; Takase S; Takemoto M; Chishaki A; Sunagawa K
    Am J Hypertens; 2015 Apr; 28(4):444-51. PubMed ID: 25352232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.